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 Children infected with Shiga toxin–
 producing bacteria can develop a clinical-
pathological entity named hemolytic 
uremic syndrome (HUS). 1 Shiga-like tox-
ins (Stx), also named verotoxins (VTs), are 
made up of one A subunit, which medi-
ates the cytotoxic activity of the toxin, and 
a pentamer of B subunits, responsible for 
binding the glycosphingolipid (GSL) glo-
botriaosyl ceramide (Gb 3 ), which is the 
functional receptor expressed on target 
cells. 1,2 A1 er binding to Gb 3 , the B sub-
units undergo endocytosis and retrograde 
transport from the cell surface to the 
Golgi / endoplasmic reticulum network, 
acting as a carrier for the cytosolic transit 
of the A subunit. Subsequently, the A 
subunit inhibits the synthesis of proteins 
via its 28S ribosomal RNA  N -glycosidase 
activity, causing injury, apoptosis, and / or 
death of susceptible renal cells. 1,2 
 Children with Stx-induced HUS (Stx-
HUS) typically develop microangiopathic 
hemolytic anemia, thrombocytopenia, and 
acute renal failure. 1 , e central pathogenic 
feature of Stx-HUS is glomerular endothe-
lial damage, which causes platelet aggrega-
tion, impairment of fibrinolysis, and 
development of thrombotic microangio-
pathic lesions characterized by the accu-
mulation of @ brin. 1 , e renal tubular injury 
seen in Stx-HUS has been traditionally 
considered an event secondary to renal 
ischemia caused by the glomerular and 
arteriolar thrombotic microangiopathic 
lesions. However, in the past decade, sev-
eral studies showed that whereas the cyto-
toxic response of cultured human 
glomerular endothelial cells to Stx is vari-
able, 1 primary human renal tubular epithe-
lial cells are very sensitive to these e- ects. 3 
, ese @ ndings generated a new paradigm 
to explain the pathogenesis of Stx-HUS: 
brieS y, that Stx induce direct tubular epi-
thelial injury, causing the release of 
cytokines and the recruitment of inS am-
matory cells that induce endothelial 
injury. 3,4 , is paradigm, however, failed to 
explain why children and adults do not 
develop isolated renal tubular injury when 
infected with Stx-producing bacteria. 
Moreover, studies in rodents that express 
Gb 3 only in renal tubular cells also support 
the notion that Stx can cause signi@ cant 
tubular injury without necessarily causing 
glomerular thrombotic micro-angiopathic 
lesions. 1 
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 The binding of Shiga-like toxins (Stx) to globotriaosyl ceramide (Gb 3 ) in 
renal cells plays a central role in Stx-induced hemolytic uremic 
syndrome (Stx-HUS). Khan  et al. show that the presence of Gb 3 within 
lipid raft microdomains in glomerular but not tubular cells may be the 
basis for the glomerular- and age-restricted pathology of Stx-HUS. They 
also propose that the binding of the HIV-1 glycoprotein gp120 to Gb 3 in 
renal tubules may play a role in HIV nephropathy. 
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 The study by Khan  et al. 2 (this issue) 
o- ers a much needed explanation to resolve 
this dilemma. , ey propose that Gb 3 within 
lipid raft microdomains in the plasma 
membrane makes glomerular endothelial 
cells more sensitive to the cytotoxic e- ects 
of Stx. , eir conclusion is based on the fol-
lowing assumptions: (1) VT cytotoxicity in 
cultured cells is dependent on Gb 3 presen-
tation within GSL- and cholesterol-
enriched plasma membrane microdomains, 
or  ‘ lipid ra1 s ’ ( Figure 1a ); (2) Gb 3 presenta-
tion within detergent-resistant membranes 
(DRMs) contains lipid ra1 s; and (3) non-
DRM Gb 3 mediates the binding and traf-
@ cking of VT to lysosomes for degradation 
( Figure 1b ). To assess the relative strength 
of lateral interaction within GSL and cho-
lesterol in the plasma membrane of glomer-
ular and tubular cells, Khan  et al. 2 exposed 
frozen human renal sections to a mild non-
ionic detergent extraction. Subsequently, 
they performed binding studies and found 
that the binding of VT to renal glomeruli 
was largely una- ected by detergent extrac-
tion, suggesting that glomerular Gb 3 is 
within DRMs ( Figure 1a ). In contrast, the 
binding of VT to renal tubular cells was lost 
by detergent extraction, and therefore the 
Gb 3 bound by VT in these cells is non-
DRM Gb 3 ( Figure 1b ). Khan  et al. 2 found 
that the Gb 3 bound by VT in mouse renal 
tubular cells is also non-DRM Gb 3 , but they 
do not explain how mice exposed to Stx 
develop renal tubular injury or discuss the 
role of inS ammatory cytokines in this proc-
ess. Nevertheless, their @ ndings explain the 
susceptibility of young children to Stx-HUS 
and open possibilities for developing new 
treatments. 
 Another interesting observation by 
Khan  et al. 2 is that the HIV-1 envelope 
glycoprotein gp120 binds to renal tubular 
Gb 3 in a VT-1-dependent and detergent-
sensitive manner. They speculate that 
these interactions may play a role in the 
pathogenesis of HIV-associated neph-
ropathy, a renal disease characterized by 
severe tubulointerstitial injury and micro-
cystic lesions. 5 However, the potential 
mechanisms by which gp120 may a- ect 
the outcome of this renal disease remain 
largely unknown. 
 gp120 is a glycoprotein that constitutes 
the envelope surface unit of the HIV-1 
virus. 6 HIV-1 enters permissive cells via a 
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these GSLs can modulate the entry of 
HIV-1 into permissive cells even in the 
absence of CD4. 7 In summary, the high 
Gb 3 content detected in renal tubules of 
children with HIV-HUS ( Figure 1b ) may 
enhance the attachment, binding, and 
endocytosis of HIV-1 to renal tubular cells 
and / or facilitate its interactions with other 
GSLs or cell-surface molecules that bind 
HIV-1, such as heparan sulfate proteogly-
cans 6 or the Du- y antigen receptor for 
chemokines (DARC) ( Figure 1b ). 10 Viral 
infectivity could be increased by such 
interactions, but more studies are needed 
to validate this hypothesis. 
series of interactions between the glyco-
protein gp120-gp41 and its cell-surface 
 receptor and coreceptors CD4, CXCR4, 
and CCR5. 6,7 Previous studies have shown 
that GSL – cholesterol ra1  microdomains 
can modulate the recruitment and assem-
bly of HIV receptors and gp120 in the 
plasma membrane of permissive cells. 7 
Moreover, a drug that mimics the aglycone 
structure of Gb 3 can block the infection of 
these cells. 8 Renal sections harvested from 
children with HIV-HUS ( Figure 1b ) and 
HIV-transgenic mice with renal disease 
show a remarkable expression of Gb 3 in 
dilated tubular structures and renal 
 microcysts. 5 , us, when all these studies 
are taken together, they suggest that the 
gp120 – Gb 3 interactions may play a direct 
role in the pathogenesis of HIV-HUS. 
However, renal tubular epithelial cells har-
vested from HIV-infected children do not 
express detectable protein levels of CD4, 
CXCR4, and CCR5, 9 and the Gb 3 bound 
by gp120 in renal tubules is non-DRM Gb 3 
 ( Figure 1b ). , erefore, these interactions 
do not appear to be linked to major HIV 
receptors / coreceptors, or to lipid raft–
associated signaling pathways. Neverthe-
less, gp120 has affinity for galactosyl 
ceramide and the GM3 ganglioside, and 
 Figure 1  |  Biological model to explain the binding and trafficking of Stx and HIV-1 through renal glomerular and tubular cells. Fluorescent 
Stx-1 binding studies were performed in 5-  m frozen renal sections harvested from children without renal disease ( a ), and with HIV-HUS ( b ), using 
fluorescein isothiocyanate-labeled Stx-1B subunit (green) as previously described. 5 ( a ) According to Khan  et al. , 2 Gb 3 within detergent-resistant 
membranes (DRMs) or lipid raft microdomains in the plasma membrane of glomerular endothelial cells is required for the retrograde transport of Stx, 
and the induction of signaling or cytotoxic events in these cells. ( b ) A remarkable expression of Gb 3 is shown in microcystic renal tubules of a child 
with HIV-HUS. According to Khan  et al. , 2 non-DRM plasma membrane Gb 3 within tubular epithelial cells mediates binding of Stx and its potential 
subsequent trafficking to lysosomes for degradation. The HIV envelope glycoprotein gp120 also shows binding to non-DRM Gb 3 . Gb 3 , in combination 
with heparan sulfate proteoglycans, 6 the Duffy antigen receptor for chemokines (DARC), 10 and other glycosphingolipids 7,8 on the cell surface of renal 
tubular epithelial cells, may enhance the viral infectivity and development of tubulointerstitial lesions in children with HIV-HUS. 
Gb3 signaling domain enriched in phospholipids and cholesterol.
Retrograde transport of Stx to the Golgi apparatus.
Inhibition of protein synthesis, apoptosis, and/or cell death.
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 Finally, the study by Khan  et al. 2 pro-
vides an interesting example of the mul-
tiple dilemmas that scientists face when 
attempting to explain the pathogenesis of 
renal diseases on the basis of isolated  ex 
vivo or  in vitro studies. For instance, the 
lack of glomerular gp120 binding to Gb 3 
should be interpreted with caution 
because these studies do not mimic the 
natural mechanism by which HIV-1 inter-
acts with glomerular endothelial cells. 
Learning how HIV-1 or gp120 may be 
able to pass or interact with glomerular 
endothelial cells to reach podocytes and 
tubular epithelial cells would be an essen-
tial step to improve our understanding of 
HIV-associated nephropathy and HIV-
HUS. As discussed above regarding chil-
dren with Stx-HUS, previous  ex vivo and 
 in vitro studies provide similarly conS ict-
ing results regarding the pathogenesis of 
HIV-HUS. For example, the expression of 
DARC in glomerular endothelial cells is 
upregulated in renal sections harvested 
from children with HIV-HUS. 10 However, 
cultured primary human glomerular 
endothelial cells do not express DARC 
protein. In contrast, cultured primary 
human renal glomerular endothelial cells 
express CXCR4 protein and can fuse with 
cells expressing HIV-gp120 by a CD4-
independent mechanism. 9 , ese @ ndings 
suggest that HIV-1 can interact with 
glomerular endothelial cells via CXCR4, 
although CXCR4 cannot be detected in 
renal glomeruli from children with HIV-
HUS (P.E.R. unpublished observations). 
In a similar manner, going back to the 
pathogenesis of Stx-HUS, renal glomeru-
lar endothelial cells from primates are 
Gb 3 -negative  in situ but express Gb 3 in 
culture and are sensitive to Stx-induced 
cytopathology. 4 Finally, Khan  et al. 2 
showed less VT staining in adult glomer-
uli compared with pediatric glomeruli 
and found that the VT binding to adult 
glomeruli could be  ‘ unmasked ’ by removal 
of the lipid composition of the plasma 
membranes with detergents or choles-
terol-removing drugs. Overall, these @ nd-
ings suggest that the adult glomerular VT 
binding sites might be protected from 
toxin binding by unknown factors that are 
susceptible to detergent extraction, and 
they explain the age-and glomerular-
restricted pathology of Stx-HUS. 
 In summary, Khan  et al. 2 have refocused 
the pathological paradigm of Stx-HUS on 
glomerular endothelial cells and explained 
why young children develop Stx-HUS. 
Their findings may also improve our 
understanding of the pathogenesis of HIV 
nephropathy and HIV-HUS. Hopefully, 
more studies will follow their lead and 
con@ rm or expand these relevant clinical 
observations. 
 DISCLOSURE 
 The author declared no competing interests. 
 ACKNOWLEDGMENTS 
 I would like to thank Anu Puri for her helpful 
suggestions. This work was supported by 
National Institutes of Health grants RO1 
DK49419 and HL55605. 
 REFERENCES 
 1 .  Ray  PE ,  Liu  X-H .  Pathogenesis of Shiga toxin-
induced hemolytic uremic syndrome .  Pediatr 
Nephrol  2001 ;  16 :  823 – 839 . 
 2 .  Khan  F ,  Proulx  F ,  Lingwood  CA .  Detergent-resistant 
globotriaosyl ceramide may define verotoxin/
glomeruli-restricted hemolytic uremic syndrome 
pathology .  Kidney Int  2009 ;  75 :  1209–1216 . 
 3 .  Hughes  AK ,  Stricklett  PK ,  Kohan  DE .  Cytotoxic 
effect of Shiga toxin-1 on human proximal tubule 
cells .  Kidney Int  1998 ;  54 :  426 – 437 . 
 4 .  Taylor  FB ,  Tesh  VL ,  De Bault  L  et al.  Characterization of 
the baboon responses to Shiga-like toxin: descriptive 
study of a new primate model of toxic responses to 
Stx-1 .  Am J Pathol  1999 ;  154 :  1285 – 1299 . 
 5 .  Liu  X-H ,  Lingwood  CA ,  Ray  PE .  Recruitment of renal 
tubular epithelial cells expressing verotoxin-1 (Stx-
1) receptors in HIV-1 transgenic mice with renal 
disease .  Kidney Int  1999 ;  55 :  554 – 561 . 
 6 .  Crublet  E ,  Andrieu  J-P ,  Vives  RR  et al.  The HIV-1 
envelope glycoprotein gp-120 features four 
heparan sulfate binding domains including the 
coreceptor binding site .  J Biol Chem  2008 ;  283 : 
 15193 – 15200 . 
 7 .  Viard  M ,  Parolini  I ,  Rawat  SS  et al.  The role of 
glycosphingolipids in HIV-signaling entry and 
pathogenesis .  Glycoconj J  2004 ;  20 :  213 – 222 . 
 8 .  Lund  N ,  Branch  DR ,  Mylvaganam  M  et al.  A novel 
soluble mimic of the glycolipid, globotriaosyl 
ceramide inhibits HIV infection .  AIDS  2006 ;  20 : 
 333 – 343 . 
 9 .  Ray  PE ,  Soler Garcia  AA ,  Xu  L  et al.  Fusion of HIV-1 
envelope-expressing cells to human glomerular 
endothelial cells through CXCR4-mediated 
mechanism .  Pediatr Nephrol  2005 ;  20 :  1401 – 1409 . 
 10 .  Liu  X-H ,  Hadley  TJ ,  Xu  X  et al.  Up-regulation of 
Duffy antigen receptor in children with renal 
disease .  Kidney Int  1999 ;  55 :  1491 – 1500 . 
see original article on page 1166
 1 King ’ s College  London, Department of Renal 
Medicine, Rayne Institute ,  London ,  UK  
 Correspondence: Qihe Xu, King ’ s College 
London, Department of Renal Medicine, Rayne 
Institute, 123 Coldharbour Lane, London SE5 9NU, 
UK. E-mail:  qihe.xu@kcl.ac.uk 
 Ablation of  klotho and premature 
aging: is 1,25-dihydroxyvitamin D 
the key middleman? 
 Yuen  Fei Wong 1 and  Qihe  Xu 1 
 The reversal of soft-tissue abnormalities and prolonged lifespan 
observed in  klotho  – / –  mice following genetic inactivation of 
1 a -hydroxylase underscores the pathophysiological role of 
1,25-dihydroxyvitamin D in mediating some of the premature 
aging-like features observed in  klotho  – / –  mice. 
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 Mutation in the  klotho gene of mice ( kl / kl ) 
was @ rst reported by Kuro-o  et al. in 1997, 
characterized by the mice ’ s distinct features 
similar to those observed in the course of the 
aging process in humans. 1 , e associated 
syndrome observed in  kl / kl mice was 
 recapitulated in  klotho knockout mice 
( klotho  – / –  ) described by Tsujikawa  et al. , and 
the phenotypes were described as premature 
aging-like rather than natural aging. 2 Over-
expression of  klotho in mice, on the other 
hand, resulted in an extension of lifespan. 
More important, the  tissue-speci@ c  in vivo 
